NCT07816731 · ACTIVE NOT RECRUITING

EFFECT OF FACE-TO-FACE AND VIRTUAL REALITY-BASED SALUTOGENESIS NURSING CARE IN PATIENTS WITH DEMENTIA

This study tests a nursing care approach called the Salutogenesis Model, delivered either in person or through virtual reality, for people already living with mild to moderate dementia. It measures whether the care improves their sense of coherence and quality of life, compared to usual care. This is an early-stage nursing study, not a drug trial, so it is about care delivery, not disease treatment.

You may qualify if

  • -Individuals aged 18 years and older.
  • Individuals who are able to read and write.
  • Individuals with a Standardized Mini-Mental Test (SMMT) score between 11 and 23, indicating mild to moderate dementia.
  • Individuals without severe speech or language impairments that would limit communication.
  • Individuals with non-progressive or clinically stable dementia, defined as cognitive symptoms that do not show marked deterioration over time.
  • Individuals who have provided written informed consent, or whose legal representative has provided written informed consent.
  • Individuals who are able to participate in the intervention sessions using virtual reality headsets independently or with the support of a caregiver.

You're excluded if

  • Inability to complete assessments due to severe psychotic symptoms (e.g., hallucinations, paranoid thoughts) or uncontrolled behavioral symptoms such as aggression or severe agitation.
  • Presence of progressive neurological diseases that impair motor and cognitive functions, such as Parkinson's disease or Huntington's disease.
  • A Standardized Mini-Mental Test (SMMT) score below 10.
  • Being older than 80 years of age.
  • Absence of a caregiver.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-10-06

View full record on ClinicalTrials.gov

All APOE4 clinical trials